Check-Cap Ltd (NASDAQ:MBAI) Short Interest Update

Check-Cap Ltd (NASDAQ:MBAI) was the target of a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 127,049 shares, a growth of 93.4% from the May 31st total of 65,685 shares. Based on an average trading volume of 67,215 shares, the short-interest ratio is presently 1.9 days. Currently, 1.8% of the company’s shares are short sold.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Check-Cap in a report on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Check-Cap Trading Down 1.2%

Shares of NASDAQ MBAI traded down $0.01 during midday trading on Wednesday, hitting $1.24. The company’s stock had a trading volume of 14,070 shares, compared to its average volume of 1,308,347. Check-Cap has a 12-month low of $0.59 and a 12-month high of $3.92. The firm has a market capitalization of $9.00 million, a price-to-earnings ratio of -0.45 and a beta of 0.59. The business’s 50 day moving average price is $1.54.

About Check-Cap

Check-Cap Ltd. (NASDAQ: MBAI) is an Israel-based medical technology company focused on non-invasive screening solutions for colorectal cancer. The company develops an ingestible imaging capsule and associated detection system intended to provide a patient-friendly alternative to traditional colonoscopy and CT colonography for colorectal screening and polyp detection.

Check-Cap’s technology centers on a swallowable capsule that acquires images of the colon as it traverses the gastrointestinal tract; external detectors capture the transmitted signals and software reconstructs images for clinical review.